# FDA 483 - Mimi Liu, MD - August 18, 2023

Source: https://www.keypedia.com/records/483/mimi-liu-md/c0f60b2f-0032-4a88-95b6-9b90e2e94843

> FDA 483 for Mimi Liu, MD on August 18, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mimi Liu, MD
- Inspection Date: 2023-08-18
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Mimi Liu, MD, a clinical investigator in Lakewood, CO, revealed a significant issue with adherence to an investigational plan. The firm failed to ensure safety follow-up calls were performed within the required time frame for multiple subjects across several visit dates, indicating a lapse in patient safety monitoring during a clinical trial.

## Related Officers

- [Jonathan R. Campos](https://www.keypedia.com/people/jonathan-r-campos/f4c6aba7-d0fe-43d2-95ae-5eb86a6659a4)

Company: https://www.keypedia.com/companies/mimi-liu-md/741fe10b-3cc9-4036-9c4c-18998ba5fd93

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face